The Real-Life Study Evaluating The Efficacy And Safety of Ponatinib « TOPASE » Reveals Induction of Deep Molecular Responses in a Cohort of 75 TKI-Resistant or Intolerant patients with CML
2020 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations